- Home
- GORO vs ICAD Comparison
GORO vs ICAD Comparison
Compare GORO & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORO
- ICAD
- Stock Information
- Founded
- GORO 1998
- ICAD 1984
- Country
- GORO United States
- ICAD United States
- Employees
- GORO N/A
- ICAD N/A
- Industry
- GORO Precious Metals
- ICAD Medical/Dental Instruments
- Sector
- GORO Basic Materials
- ICAD Health Care
- Exchange
- GORO Nasdaq
- ICAD Nasdaq
- Market Cap
- GORO 40.2M
- ICAD 40.8M
- IPO Year
- GORO N/A
- ICAD 1986
- Fundamental
- Price
- GORO $0.16
- ICAD $1.54
- Analyst Decision
- GORO Strong Buy
- ICAD
- Analyst Count
- GORO 1
- ICAD 0
- Target Price
- GORO $1.75
- ICAD N/A
- AVG Volume (30 Days)
- GORO 2.5M
- ICAD 279.9K
- Earning Date
- GORO 11-05-2024
- ICAD 11-13-2024
- Dividend Yield
- GORO N/A
- ICAD N/A
- EPS Growth
- GORO N/A
- ICAD N/A
- EPS
- GORO N/A
- ICAD N/A
- Revenue
- GORO $73,897,000.00
- ICAD $18,940,000.00
- Revenue This Year
- GORO N/A
- ICAD $13.15
- Revenue Next Year
- GORO $48.90
- ICAD $24.28
- P/E Ratio
- GORO N/A
- ICAD N/A
- Revenue Growth
- GORO N/A
- ICAD 10.03
- 52 Week Low
- GORO $0.12
- ICAD $1.18
- 52 Week High
- GORO $0.71
- ICAD $2.65
- Technical
- Relative Strength Index (RSI)
- GORO 40.99
- ICAD 40.50
- Support Level
- GORO $0.12
- ICAD $1.45
- Resistance Level
- GORO $0.17
- ICAD $1.60
- Average True Range (ATR)
- GORO 0.01
- ICAD 0.17
- MACD
- GORO 0.01
- ICAD -0.07
- Stochastic Oscillator
- GORO 73.25
- ICAD 9.28
About GORO Gold Resource Corporation
Gold Resource Corp is a gold and silver producer, developer, and explorer with operations in Oaxaca, Mexico, and Nevada, USA. It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.